Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA)

CUSIP: 921659108

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
59,128,667
Total 13F shares
45,005,222
Share change
+1,103,109
Total reported value
$212,432,729
Put/Call ratio
7240%
Price per share
$4.72
Number of holders
137
Value change
+$5,358,364
Number of buys
69
Number of sells
72

Security key

921659108

Report period

Q2 2025

Institutions

137

Top holders

10

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F 13D/G
Company
8.1%
from 13D/G
9,129,921
$41,906,338 31 Mar 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
6%
3,566,425
$16,369,891 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
5.9%
3,495,284
$16,043,353 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
4.3%
2,539,675
$11,657,428 31 Mar 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
4%
2,353,307
$10,801,679 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.6%
2,139,591
$9,820,723 31 Mar 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
3.2%
1,887,049
$8,658,000 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.7%
1,613,641
$7,408,356 31 Mar 2025
13F
STATE STREET CORP
13F
Company
2.1%
1,252,559
$5,749,246 31 Mar 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
1.6%
929,644
$4,267,066 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
1.6%
916,720
$4,207,745 31 Mar 2025
13F
Krensavage Asset Management, LLC
13F
Company
1.3%
754,381
$3,463,000 31 Mar 2025
13F
FEDERATED HERMES, INC.
13F
Company
1.2%
726,915
$3,336,540 31 Mar 2025
13F
PRUDENTIAL FINANCIAL INC
13F
Company
1.2%
710,710
$3,262,159 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.2%
693,852
$3,184,781 31 Mar 2025
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
1.1%
666,461
$3,125,702 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.83%
489,374
$2,246,227 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.8%
475,865
$2,184,220 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.75%
440,561
$2,022,175 31 Mar 2025
13F
CITIGROUP INC
13F
Company
0.67%
396,490
$1,819,889 31 Mar 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.64%
379,001
$1,739,614 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.59%
350,601
$1,609,259 31 Mar 2025
13F
Profit Investment Management, LLC
13F
Company
0.56%
329,822
$1,513,883 31 Mar 2025
13F
Monaco Asset Management SAM
13F
Company
0.55%
325,000
$1,491,750 31 Mar 2025
13F
SEI INVESTMENTS CO
13F
Company
0.54%
320,199
$1,469,718 31 Mar 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.47%
278,791
$1,279,651 31 Mar 2025
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.46%
274,293
$1,259,005 31 Mar 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.45%
265,888
$1,220,426 31 Mar 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.44%
260,215
$1,194,000 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.42%
248,106
$1,138,806 31 Mar 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.4%
235,200
$1,079,568 31 Mar 2025
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.37%
220,448
$1,011,856 31 Mar 2025
13F
Invesco Ltd.
13F
Company
0.35%
204,964
$940,785 31 Mar 2025
13F
Trexquant Investment LP
13F
Company
0.32%
192,110
$881,785 31 Mar 2025
13F
Universal- Beteiligungs- und Servicegesellschaft mbH
13F
Individual
0.32%
190,536
$874,560 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.32%
190,365
$873,775 31 Mar 2025
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.32%
186,993
$858,298 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.3%
175,632
$806,151 31 Mar 2025
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.3%
174,859
$802,603 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.29%
171,313
$786,327 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.28%
168,093
$771,547 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.27%
158,780
$728,800 31 Mar 2025
13F
FMR LLC
13F
Company
0.27%
158,663
$728,265 31 Mar 2025
13F
Richard W. Dugan
3/4/5
Director
0.3%
177,454
$700,943 05 Jun 2025
Empire Financial Management Company, LLC
13F
Company
0.25%
150,000
$688,500 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.25%
147,722
$678,044 31 Mar 2025
13F
KLP KAPITALFORVALTNING AS
13F
Company
0.23%
135,400
$621,486 31 Mar 2025
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.23%
135,144
$620,311 31 Mar 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.23%
134,431
$617,038 31 Mar 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.21%
125,700
$576,963 31 Mar 2025
13F

Institutional Holders of Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA) as of Q2 2025

As of 30 Jun 2025, Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,005,222 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and Krensavage Asset Management, LLC. This page lists 136 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
145
Q2 2025 holders
137
Holder diff
-8
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .